Henry Schein | HSIC - Sales Revenues

Stock Price
72.71
Daily Change
-0.01 -0.01%
Monthly
-8.14%
Yearly
1.21%
Q2 Forecast
71.26

Henry Schein reported $3.37B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Agilent USD 1.8B 63M Dec/2025
Align Technology USD 1.04B 10M Mar/2026
Bruker USD 823.4M 153.8M Mar/2026
Cardinal Health USD 60.9B 4.73B Mar/2026
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Cigna USD 68.52B 3.95B Mar/2026
Concord Medical Services Hldg CNY 200.61M 83.9M Jun/2025
Cooper Companies USD 1.02B 41.1M Dec/2025
CVS Health USD 100.4B 5.3B Mar/2026
Danaher USD 5.95B 890M Mar/2026
Dentsply International USD 880M 81M Mar/2026
Encompass Health USD 1.59B 50M Mar/2026
Henry Schein USD 3.37B 30M Mar/2026
Idexx Laboratories USD 1.14B 50M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
Laboratory Of America USD 3.54B 20M Mar/2026
McKesson USD 92.3B 13.86B Mar/2026
Mettler Toledo International USD 947.13M 182.87M Mar/2026
Owens Minor USD 708.97M 11.71M Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Revvity USD 711M 61.06M Mar/2026
Stryker USD 6B 1.2B Mar/2026
Tenet Healthcare USD 5.37B 160M Mar/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Universal Health Services USD 4.49B 0 Mar/2026
Veradigm USD 142.52M 9.38M Dec/2022
Waters USD 1.27B 338M Mar/2026
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026
Zoetis USD 2.3B 100M Mar/2026